The cancer radiation therapy market is expanding rapidly, driven by the rising incidence of cancer, technological advancements in radiation delivery systems, and growing preference for non-invasive treatment options. According to Business Market Insights, the market was valued at USD 57.88 billion in 2024 and is expected to reach USD 136.16 billion by 2031, registering a strong CAGR of 13.00% during the forecast period from 2025 to 2031.

Cancer radiation therapy uses high-energy radiation (such as X-rays, gamma rays, or protons) to destroy cancer cells, shrink tumors, and relieve symptoms. It is used as a standalone treatment or in combination with surgery, chemotherapy, and immunotherapy. Modern techniques like Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), and Proton Therapy allow for highly precise targeting while minimizing damage to surrounding healthy tissues.

Download Sample Pdf : https://www.businessmarketinsights.com/sample/BMIPUB00031707

Market Overview

The market is segmented by type, cancer type, and end user.

• By Type: External Beam Radiation Therapy (EBRT) dominated the market in 2024 due to its precision, versatility, and widespread availability in hospitals. Internal Beam Radiation Therapy (Brachytherapy) is also growing steadily.
• By Cancer Type: Breast Cancer held the largest share in 2024, followed by Lung Cancer, Prostate Cancer, Cervical Cancer, Head & Neck Cancer, and Colorectal Cancer. Breast cancer leads due to high global incidence and standard use of radiation therapy post-surgery.
• By End User: Hospitals accounted for the largest share, as they are equipped with advanced radiation oncology departments and handle the majority of cancer cases. Ambulatory & Radiotherapy Centers are growing rapidly due to cost-effectiveness and convenience.

Key Growth Drivers and Opportunities

1. Rising Global Cancer Incidence Increasing cancer cases due to aging populations, lifestyle changes, and environmental factors are driving demand for effective radiation therapy solutions.

2. Technological Advancements Innovations such as image-guided radiation therapy (IGRT), stereotactic radiosurgery, proton therapy, and AI-powered treatment planning are making radiation therapy more accurate, effective, and patient-friendly.

3. Growing Preference for Non-Invasive Treatments Patients and physicians increasingly prefer radiation therapy over surgery due to fewer complications, shorter recovery times, and the ability to treat tumors in inoperable locations.

4. Expansion in Emerging Markets Improving healthcare infrastructure, rising cancer awareness, and government initiatives for cancer care in Asia-Pacific and other developing regions are creating significant growth opportunities.

Regional Insights

Asia-Pacific is expected to witness the fastest growth during the forecast period. Rapid urbanization, increasing cancer burden, expanding healthcare infrastructure, and government support for advanced cancer treatment in China, India, Japan, and South Korea are key drivers.

North America currently holds a substantial market share, supported by advanced technology adoption, high healthcare spending, and strong presence of leading players in the United States and Canada.

Europe maintains steady growth with emphasis on precision medicine and advanced radiation techniques.

Competitive Landscape

The market is competitive, with key players focusing on technological innovation, strategic partnerships, and geographic expansion. Major companies include:

• Accuray Incorporated
• Elekta
• Varian Medical Systems (Siemens Healthineers)
• Brainlab AG
• IBA Worldwide
• Mevion Medical Systems
• Hitachi High-Tech Corporation
• Canon Medical Systems
• Isoray Inc.

These companies are investing heavily in next-generation systems, including AI integration and compact proton therapy solutions.

Challenges

• High cost of advanced radiation therapy equipment
• Shortage of skilled radiation oncologists and technicians in some regions
• Limited access in rural and low-income areas

Future Trends

• Wider adoption of proton therapy and MR-guided radiation
• Integration of Artificial Intelligence in treatment planning
• Growth of hypofractionated radiation therapy (fewer sessions)
• Expansion of outpatient and ambulatory radiotherapy centers
• Personalized radiation therapy based on tumor genetics

Conclusion

The cancer radiation therapy market is set for impressive growth as radiation remains a cornerstone of modern cancer treatment. With continuous technological advancements making therapy more precise and effective, the industry is evolving rapidly to meet the growing global demand for better cancer care.

As cancer incidence continues to rise and healthcare systems invest in advanced treatment infrastructure, radiation therapy will play an increasingly vital role in improving survival rates and quality of life for cancer patients worldwide.

Related URLS 

https://www.businessmarketinsights.com/reports/cancer-targeted-therapy-market

https://www.businessmarketinsights.com/reports/cancer-chemotherapy-market

https://www.businessmarketinsights.com/reports/cancer-therapeutics-market

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Contact us:

• If you have any questions about this report or would like further information, please contact us:
• Contact person: Ankit Mathur
• Email: sales@businessmarketinsights.com
• Phone: +16467917070